| 000 | 01613 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515020512.0 | ||
| 264 | 0 | _c20070329 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a1381-6128 | ||
| 024 | 7 |
_a10.2174/138161206776055985 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorrow, Jason D | |
| 245 | 0 | 0 |
_aThe isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2006 |
||
| 300 |
_a895-902 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArachidonic Acid _xmetabolism |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 |
_aBronchoconstrictor Agents _xpharmacology |
| 650 | 0 | 4 |
_aDinoprost _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDinoprostone _xanalogs & derivatives |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoprostanes _xbiosynthesis |
| 650 | 0 | 4 |
_aKidney _xblood supply |
| 650 | 0 | 4 | _aLipid Peroxidation |
| 650 | 0 | 4 |
_aLung _xblood supply |
| 650 | 0 | 4 | _aOxidative Stress |
| 650 | 0 | 4 |
_aPulmonary Circulation _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Prostaglandin E _xdrug effects |
| 650 | 0 | 4 | _aReceptors, Prostaglandin E, EP2 Subtype |
| 650 | 0 | 4 |
_aReceptors, Thromboxane _xmetabolism |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 12 _gno. 8 _gp. 895-902 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138161206776055985 _zAvailable from publisher's website |
| 999 |
_c16142173 _d16142173 |
||